Authors
»
OBG OPD No Shri BM Patil Hospital And Research Centre -More
Category
»
Primary study
Registry of Trials»Clinical Trials Registry - India
Year
»
2026
INTERVENTION: Intervention1: TAP Block Administration (Group A): Performed under landmark technique after caesarean section. Ropivacaine (0.75%) 10 ml on both sideswill be injected bilaterally into the transversus abdominis plane Control Intervention1: Intravenous Diclofenac (Group B): Standard diclofenac dose administered postoperatively at a defined time interval at 30 mins, 2 hrs, 4 hrs, 6 hrs, 8 hrs, 12 hrs CONDITION: Health Condition 1: O998‐ Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium Health Condition 2: O94‐ Sequelae of complication of pregnancy, childbirth, and the puerperium PRIMARY OUTCOME: Postoperative pain scores assessed using the Visual Analogue Scale (VAS) at various intervalsTimepoint: 30mins, 2h, 4h, 6h, 8h,12h, 24h post‐surgery SECONDARY OUTCOME: Duration of analgesia (time until first request for rescue analgesia). ; Total analgesic consumption (requirement for additional pain medication within 24 hours). ; Side effects & complications, such as nausea, vomiting, sedation, or local anaesthetic toxicity. ; Maternal satisfaction scores regarding pain relief using a Likert scale or similar assessment tool. ; Postoperative mobility & recovery measures (e.g. time to first ambulation). ; Timepoint: 30mins, 2h, 4h, 6h, 8h,12h, 24h post‐surgery INCLUSION CRITERIA: Pregnant women undergoing elective or emergency caesarean section under spinal anaesthesia. Age between 18 40 years. ASA (American Society of Anaesthesiologists physical status I or II. Willing to participate and provide informed consent.
Epistemonikos ID: 669c37731bf7f106bc4d5f130a37605cc284eccd
First added on: Oct 08, 2026